AMP Middle East 2025 Recordings

The Association for Molecular Pathology proudly hosted AMP Middle East at the Cleveland Clinic Abu Dhabi in April 2025, bringing together molecular pathologists and diagnosticians from around the world. This premier two-day event featured expert-led sessions, interactive discussions, and valuable networking opportunities, all tailored to the unique clinical and diagnostic challenges of the Middle East across AMP’s areas of focus—genetics, hematopathology, informatics, infectious diseases, and solid tumors. Recordings of key sessions, panels, and industry discussions are now available, offering insights from thought leaders, practical strategies, and updates on regional advancements in molecular pathology.  

What You Will Learn

• Latest advances in molecular diagnostics, genomics, and biomarker development

• Clinical applications in oncology, infectious diseases, and inherited genetic disorders

• Integration of next-generation sequencing, liquid biopsy, and bioinformatics into routine practice

• Regional perspectives on implementing precision medicine and molecular testing

• Quality assurance, regulatory considerations, and laboratory best practices

Event Details

• Event: Association for Molecular Pathology Middle East 2025

• Format: In-person conference with selected virtual access

• Program Highlights: Keynote presentations, case-based discussions, workshops, and industry exhibits

• Topics Covered: Precision oncology, genetic testing, infectious disease diagnostics, molecular imaging, and emerging technologies

Who Should Attend
Molecular pathologists, clinical laboratory directors, geneticists, oncologists, infectious disease specialists, researchers, and laboratory technologists. The meeting is also valuable for healthcare policymakers, biotechnology and pharmaceutical professionals, and trainees in molecular medicine.

Why Attend
This event offers a unique platform to learn from world-class faculty while addressing the specific challenges and opportunities in the Middle East. Attendees will leave with advanced knowledge, practical strategies, and valuable connections to accelerate the adoption of molecular pathology and precision medicine in their practice or institution.